Education
About Us
Working with TipRanks
Follow Us
NanoVibronix Inc (NAOV)
NASDAQ:NAOV
NAOV Stock Chart & Stats
$4.10
$0.01(2.03%)
At close: 4:00 PM EST
$4.10
$0.01(2.03%)
Day’s Range― - ―
52-Week Range$3.55 - $162.50
Previous CloseN/A
Volume412.44K
Average Volume (3M)31.48K
Market Cap
$4.57M
Enterprise ValueN/A
Total Cash (Recent Filing)$6.95M
Total Debt (Recent Filing)$3.17M
Price to Earnings (P/E)―
Beta3.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.72
Shares Outstanding1,088,176
10 Day Avg. Volume28,365
30 Day Avg. Volume31,485
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)27.93
Price to Sales (P/S)6.85
P/FCF Ratio-6.95
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1,562
Revenue Forecast (FY)$4.84M
NanoVibronix News
NAOV FAQ
What was NanoVibronix Inc’s price range in the past 12 months?
NanoVibronix Inc lowest stock price was $3.55 and its highest was $162.50 in the past 12 months.
What is NanoVibronix Inc’s market cap?
NanoVibronix Inc’s market cap is $4.57M.
When is NanoVibronix Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NanoVibronix Inc’s earnings last quarter?
NanoVibronix Inc released its earnings results on Nov 16, 2021. The company reported -$562.716 earnings per share for the quarter, missing the consensus estimate of N/A by -$562.716.
Is NanoVibronix Inc overvalued?
According to Wall Street analysts NanoVibronix Inc’s price is currently Overvalued.
Does NanoVibronix Inc pay dividends?
NanoVibronix Inc does not currently pay dividends.
What is NanoVibronix Inc’s EPS estimate?
NanoVibronix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoVibronix Inc have?
NanoVibronix Inc has 1,088,176 shares outstanding.
What happened to NanoVibronix Inc’s price movement after its last earnings report?
NanoVibronix Inc reported an EPS of -$562.716 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.162%.
Which hedge fund is a major shareholder of NanoVibronix Inc?
Currently, no hedge funds are holding shares in NAOV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NanoVibronix Inc
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Technical Analysis
Ownership Overview
12.04%
Insiders
0.11% Mutual Funds
― Other Institutional Investors
87.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---